• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • CRO Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Trending
Hamburger Menu Hamburger Menu
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • CRO Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us

23andMe

3D rendering of chromosomes and circular extrachromosomal DNA
MedTech

Anne Wojcicki steps down to bid on 23andMe’s bankruptcy auction

The genetic testing company has filed for Chapter 11 bankruptcy and will pursue a court-managed sale.
Conor Hale Mar 24, 2025 10:43am
human dna structure with glass helix destroyed

23andMe shutters cancer drug research, lays off 40% of staff

Nov 11, 2024 9:07pm
23andM3 executive ring the Nasdaq opening bell on the day the company goes public

23andMine: Anne Wojcicki aims to take genetics company private

Apr 18, 2024 9:16am
DNA sequence

23andMe lands new label for cholesterol drug response report

Oct 27, 2022 11:12am
23andM3 executive ring the Nasdaq opening bell on the day the company goes public

23andMe snags 3rd FDA nod for genetic cancer risk test

Jan 10, 2022 11:58am
DNA test tube

23andMe to go public in $3.5B deal backed by Virgin

Feb 4, 2021 11:25am

Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Pharma
    • Fierce Biotech
    • Fierce Healthcare
  • Our Events
    • Life Sciences Events
©2025 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings